Point of Care (PoC) Diagnostics Market to Witness Robust Expansion throughout the Forecast Period 2020 – 2026

Point-of-care (POC) diagnostics or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours. Through the use of portable blood analysers, testing at the “point of care” streamlines the diagnostic process and helps ensure patients receive the most effective and efficient care when and where it is needed. Point-of-care (POC) diagnostic testing permits staff to make speedy triage and treatment decisions when diagnosing a patient’s condition or monitoring a treatment response. By simplifying the testing process, clinicians can focus on what matters most—providing effective, quality patient care.

Factors such as high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and rising preference for home healthcare across the globe are increasing the adoption of POC diagnostics products globally. Rising investment by multiple public organisations is even a driving factor for the growth of PoC diagnostic market. For instance, in November 2018, the Massachusetts Medical Device Development Center established a M2D2 with the support of USD 7.9 million grant from the National Institute of Health (NIH) which established a new centre to assist inventors pioneering promising new point-of-care devices and technologies for patients with heart, lung, blood and sleep disorders.

This report covers the recent COVID-19 incidence and its impact on Point of Care (PoC) Diagnostics Market. The pandemic has widely affected the economic scenario. This study assesses the current landscape of the ever-evolving business sector and the present and future effects of COVID-19 on the market.

Get a Free Sample PDF Report to understand our report before you purchase@ https://www.reportsanddata.com/sample-enquiry-form/1507

Key participants include Abbott, F. Hoffmann-La Roche and Siemens Healthineers.

Segments covered in the report:
For the purpose of the study, this Reports and Data has segmented the Global Point of Care (PoC) Diagnostics Market on the basis of product type, platform type, prescription mode, end user and the regional outlook:

Product Type (Revenue, USD Million; 2016–2026)
• Glucose Monitoring Products
o Strips
o Meters
o Lancets & Lancing Devices
• Cardiometabolic Testing Products
o Cardiac Marker Testing Products
o Blood Gas/Electrolytes Testing Products
o HBA1C Testing Products
• Infectious Disease Testing Products
o Influenza Testing Products
o HIV Testing Products
o Hepatitis C Testing Products
o Sexually Transmitted Disease (STD) Testing Products
o Healthcare-Associated Infection (HAI) Testing Products
o Respiratory Infection Testing Products
o Tropical Disease Testing Products
o Other Infectious Disease Testing Products

End User (Revenue, USD Million; 2016–2026)
• Professional Diagnostic Centres
• Clinical Laboratories (Outpatient Healthcare & Ambulatory Care Settings)
• Hospitals/Critical Care Centres
• Home Care
• Research Laboratories
• Other End Users

To buy this report at unbelievable discounts, visit @ https://www.reportsanddata.com/discount-enquiry-form/1507

Further key findings from the report suggest:
• Point of Care (PoC) Diagnostics market is fastest growing at a CAGR of 3% in Asia Pacific due to rising prevalence of strategic initiatives taken by international players to improve healthcare infrastructure and increasing awareness in developing countries like China and India
• The market for Molecular diagnostics segment is projected to have the highest CAGR during the forecasted period because of the growing advancements in technology, increasing initiatives of market players for developing POC molecular diagnostics products, and resource-limited settings
• Europe is the second largest region with a share of 33.1 % due to the increased adoption of advanced point of care diagnostic devices, rise in awareness about innovative and advanced applications of point of care diagnostic devices, and rapidly aging population coupled with increase in incidences of diabetes and liver diseases
• Cardiometabolic Testing Products is accounted to be the second leading segment which is valued at USD 5411.7 million due to increasing number of patients with cardiac disorders and a huge demand and supply of cardiometabolic products across the regions
• North America is expected to account for the 41.1% of the global Point of Care (PoC) Diagnostics market million owing to the to the prevalence of unhealthy lifestyle, high number of chronic diseases, rising number of FDA approvals and government regulations related to development of healthcare
• The prescription-based testing segment holds the largest share of the global point-of-care diagnostics market in 2018 owing to the increasing incidence and prevalence of lifestyle diseases and the lack of awareness on OTC devices in developing nations

Regional Outlook (Revenue, USD Million; 2017-2027)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)

Reasons to buy this market intelligence report:
• Detailed market evaluation both at regional and global levels.
• Significant changes in market scenario, along with an extensive competitive analysis
• Classification of the industry based on product type, application, and region
• Market segments segregated on the basis of type, application, and geography
• Comprehensive analysis of the historical data and contemporary market scenario to infer industry size, volume, share, growth, and sales
• Investigation of significant developments in the market dynamics
• Market segments and regions

To get this report with detailed market information, tables, charts, graphs, etc., reach us here@ https://www.reportsanddata.com/report-detail/point-of-care-poc-diagnostics-market

Contact Us:

John Watson
Head of Business Development
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.